about
A probability-based approach for high-throughput protein phosphorylation analysis and site localizationLarge-scale characterization of HeLa cell nuclear phosphoproteinsAutocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architectureA quantitative atlas of mitotic phosphorylationPhosphoproteomic analysis of the developing mouse brainSurvey of activated FLT3 signaling in leukemiaA tissue-specific atlas of mouse protein phosphorylation and expressionGas-phase rearrangements do not affect site localization reliability in phosphoproteomics data sets.Quantitative proteomics reveal a feedforward mechanism for mitochondrial PARKIN translocation and ubiquitin chain synthesis.Large-scale phosphorylation analysis of mouse liverEffects of MEK inhibitors GSK1120212 and PD0325901 in vivo using 10-plex quantitative proteomics and phosphoproteomics.Neutral Loss Is a Very Common Occurrence in Phosphotyrosine-Containing Peptides Labeled with Isobaric Tags.Profiling of UV-induced ATM/ATR signaling pathways.Characterization of mouse spleen cells by subtractive proteomics.Multiplexed Phosphoproteomic Profiling Using Titanium Dioxide and Immunoaffinity Enrichments Reveals Complementary Phosphorylation EventsImmunoaffinity enrichment and mass spectrometry analysis of protein methylation.Identification of anaplastic lymphoma kinase as a potential therapeutic target in ovarian cancer.Phosphoproteome analysis of Drosophila melanogaster embryos.Evaluation of the utility of neutral-loss-dependent MS3 strategies in large-scale phosphorylation analysisDisrupting protein NEDDylation with MLN4924 is a novel strategy to target cisplatin resistance in ovarian cancer.Large-scale phosphorylation analysis of alpha-factor-arrested Saccharomyces cerevisiae.Enhanced analysis of metastatic prostate cancer using stable isotopes and high mass accuracy instrumentation.Optimization and use of peptide mass measurement accuracy in shotgun proteomics.A proteomics approach for the identification and cloning of monoclonal antibodies from serumProteomics-directed cloning of circulating antiviral human monoclonal antibodies
P50
Q21735934-AE0D0FC4-E6B5-45E9-96BA-B268E7D42E76Q24300834-3261E044-56CB-495D-8AA4-1EF3FD25B583Q24338443-9B20ED57-F1A6-414B-A827-630FB6268C8FQ24646817-CD0EFA37-6CCE-425A-9450-8A58BEBA6051Q28280338-D643DA84-6306-47DB-89C8-89C0524C17B4Q28477934-8BC4500B-C350-4B8D-8CAD-636696FC4F94Q29616549-65739A50-BF93-4428-84A9-BFAC17455910Q33550932-8404C1A6-447E-4E49-8411-947A095C7B33Q34622632-575AA7C7-BA95-4C91-BB1E-B43435F69E7AQ35616333-D3954FD8-364D-495D-91E1-D1FFA161D6C3Q35891699-230F1B14-9FB2-40B2-A245-70CE62ED6CC5Q36225560-CD4C6D77-46F1-4931-B8C1-7076530D6855Q36288898-3A4608CC-DDEB-4A49-8A86-F49D7FE2679AQ38520021-E0A60E16-A0DC-44F4-A890-8F121C45A126Q38973993-BCB2EE3D-0222-4C38-9EC1-AC210B8A39D4Q39078089-D379FDF8-0B95-4A6E-AF95-D940542A3696Q39351714-D59C049F-2F90-43B5-9FC6-5D431002E607Q42199723-E0A8A59E-71B8-4799-AEA4-DE65D71493FEQ42557255-07A752BC-F998-4F62-A3BA-456178DF25F7Q45148018-A6549B49-4BC9-48FA-BD33-635623C1915EQ50232146-11D3B31D-8A75-4BBC-B41B-4C521F503375Q50232207-4DBE348B-6460-43AB-8DDC-0D7D52C49C70Q50232217-175C0E88-FFA5-45E9-84CA-1988AA23AF35Q83739906-E0771974-FDE6-4838-9247-26A234EB6951Q85397355-80BE0902-FC93-4436-BCF9-5D146C3C82B0
P50
name
Sean A Beausoleil
@en
type
label
Sean A Beausoleil
@en
prefLabel
Sean A Beausoleil
@en